Interview Questions for Danaë Delbeke, Head of Indigo Corporation

In the heart of Belgium, a pioneering company named Indigo is making waves in the medical technology sector. Specialising in nanophotonics, Indigo is developing a groundbreaking solution for diabetes patients: a minuscule, invisible sensor.

The sensor, which is inserted subcutaneously, measures blood sugar levels, ketones, body temperature, and lactate levels. This multi-functional device aims to improve the monitoring and treatment of diabetes, alleviate the psychological impact of continuous finger-pricking, and reduce the stigma of visible sensors.

In the long run, the sensor could be linked to an insulin pump, offering patients a more seamless and less intrusive method of managing their condition. For patients, using digital health products like Indigo's sensor could reduce the need for frequent physical follow-ups, lead to the greater personalization of therapies, and increase quality of life.

The COVID-19 pandemic has underscored the potential of medical technologies, and has called for an approach that expands access to care without further increasing the pressure on health systems and payers. Easing the development of digital applications by avoiding a heavy regulatory burden, and reimbursement schemes for apps, would be helpful in the development of digital health products.

Indigo's sensor is a testament to the power of collaboration. It is based on nanophotonics, a technology combining the photonics expertise of the University of Ghent with the nanoelectronics expertise of Belgian research lab Imec.

Danaë Delbeke, the CEO and founder of Indigo, is passionate about bringing this innovative technology to the masses. She hopes for more regulatory support and reimbursement schemes to launch digital health products at scale. Legislation and/or regulatory policies that enforce standards for interoperability can fast-forward the process to ensure applications become more widespread and get to the level of importance they deserve.

Indigo's system integrates advanced digital technologies such as artificial intelligence (AI), digital twin technology, and industrial software from Siemens Xcelerator, which optimize manufacturing workflows, enhance efficiency, and support sustainability in electric vehicle production. These technologies are well-suited for smart, automated, and sustainable manufacturing. However, Indigo Ag, another company with the same name, focuses on agricultural technology, specifically soil carbon measurement and carbon sequestration rather than health parameters, so it does not measure patient variables or aspects of patient condition.

Interoperability and data compatibility must become a priority of all stakeholders that develop data technologies. This will increase data flow and improve the interpretation of data between devices, apps, patients, and healthcare professionals. As Indigo continues to refine its sensor and navigates the regulatory landscape, it is clear that this innovative company is paving the way for a future where technology and healthcare seamlessly intertwine.